Wockhardt Limited's Regulatory Woes: Hard Work Ahead
|
Case Code: BSTR450 Case Length: 13 Pages Period: 2010 - 2014 Pub Date: 2014 Teaching Note: Not Available |
Price: Rs.300 Organization: Wockhardt Limited Industry: Pharmaceuticals Countries: India; Global Themes: Globalization, Competitive Strategy, International Management |
Abstract Case Intro 1 Case Intro 2 Excerpts
About Wockhardt
Wockhardt was founded in the late 1960s by Habil Khorakiwala (Habil).The company manufactured and marketed pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs), and vaccines. Headquartered in Mumbai, India, it had full- fledged operations in the US, the UK, Ireland, and France. It also had its marketing presence in emerging markets such as Russia, Brazil, Mexico, Vietnam, the Philippines, Nigeria, Kenya, Ghana, Tanzania, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon, and Kuwait. As of 2013, it had three research centers and 12 manufacturing plants across India, the US, and Europe.
The history of Wockhardt dates back to 1959, when Fakhruddin T. Khorakiwala (Fakhruddin) acquired Worli Chemical Works (WCW) which used to manufacture medicines for common ailments. In 1966, Fakhruddin's son, Habil, took charge of WCW, then a Rs.0.4 million company with 20 employees, and renamed it 'Wockhardt', which means "work hard" in German. In 1973, the company was incorporated as Wockhardt Pvt. Ltd. In 1979, it set up a pharmaceutical formulation manufacturing plant at Aurangabad, Maharashtra, India. In the same year, the company floated Wockhardt Synchem Pvt. Ltd. (WSPL) to manufacture bulk drugs at Ankleshwar, Gujarat, India. In 1983, a manufacturing facility was opened at Kalal, Gujarat, to produce nutrition foods. In the same year, WSPL was renamed Wockhardt Ltd...
Buy this case study (Please select any one of the payment options)
| Price: Rs.300 |
Price: Rs.300 | PayPal (7 USD) |
